TRACON Pharmaceuticals (TCON) Priced

Developing combination therapies with VEGF inhibitors to treat cancers.

Health Care - Biotechnology

IPO Performance
Latest Trade $3.95 0.00 (0.0%)
First Day Return -6.0%
Return from IPO -60.5%
 
TRACON Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 12/29/2014
Offer Price $10.00
Price Range $12.00 - $14.00
Offer Shares (mm) 3.6
Deal Size ($mm) 36
 
IPO Data
IPO Date 01/29/2015
Offer Price $10.00
Price Range $12.00 - $14.00
Offer Shares (mm) 3.6
Deal Size ($mm) $36
 
Underwriters
more
Business Overview
Developing combination therapies with VEGF inhibitors to treat cancers.
Developing combination therapies with VEGF inhibitors to treat cancers.
more
Company Data
Headquarters San Diego, CA
Founded 2004
Employees 13
Website www.traconpharma.com
 

Performance vs. IPO Index (IPOUSA)